{
    "Trade/Device Name(s)": [
        "N Latex FLC kappa assay",
        "N Latex FLC lambda assay"
    ],
    "Submitter Information": "Siemens Healthcare Diagnostics Products GmbH",
    "510(k) Number": "K182098",
    "Predicate Device Reference 510(k) Number(s)": [
        "K031016"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DFH",
        "DEH"
    ],
    "Summary Letter Date": "August 2, 2018",
    "Summary Letter Received Date": "August 3, 2018",
    "Submission Date": "August 29, 2018",
    "Regulation Number(s)": [
        "21 CFR 866.5550"
    ],
    "Regulation Name(s)": [
        "Immunoglobulin (light chain specific) immunological test system"
    ],
    "Analyte Class(es)": [
        "immunology"
    ],
    "Analyte(s)": [
        "Free light chain kappa",
        "Free light chain lambda"
    ],
    "Specimen Type(s)": [
        "Serum",
        "EDTA-plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "BN II",
        "BN ProSpec"
    ],
    "Method(s)/Technology(ies)": [
        "Particle-enhanced immunonephelometry"
    ],
    "Methodologies": [
        "Immunonephelometry"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for Siemens N Latex FLC kappa and lambda assays for quantitative measurement of free light chains in serum and EDTA-plasma using immunonephelometry",
    "Indications for Use Summary": "In-vitro diagnostic reagents for quantitative determination of free kappa or lambda light chains in human serum and EDTA-plasma by immunonephelometry using BN Systems, aiding in diagnosis and monitoring of multiple myeloma and amyloidosis in conjunction with other laboratory and clinical findings.",
    "fda_folder": "Immunology"
}